Literature DB >> 25377611

Role of adverse effects in medication nonadherence in bipolar disorder.

Rajnish Mago1, Dileep Borra, Rajeev Mahajan.   

Abstract

Nonadherence to medications is common and associated with poor or limited clinical outcomes in the treatment of bipolar disorder. A review of the literature discloses that adverse effects are one of the commonly reported reasons for nonadherence to mood stabilizers by patients with bipolar disorder. Nevertheless, other than such broad summaries, relatively little attention has been given to the role of adverse effects in relation to nonadherence. This review article is the first to consolidate the available data on this topic. Weight gain, perceived cognitive impairment, tremors, and sedation are the adverse effects most likely to lead to nonadherence. Further research is needed to anticipate, identify, manage, and potentially minimize the impact of adverse effects.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25377611     DOI: 10.1097/HRP.0000000000000017

Source DB:  PubMed          Journal:  Harv Rev Psychiatry        ISSN: 1067-3229            Impact factor:   3.732


  7 in total

Review 1.  Medication Adherence in Patients with Bipolar Disorder: A Comprehensive Review.

Authors:  Jennifer B Levin; Anna Krivenko; Molly Howland; Rebecca Schlachet; Martha Sajatovic
Journal:  CNS Drugs       Date:  2016-09       Impact factor: 5.749

2.  Weight changes associated with antiepileptic mood stabilizers in the treatment of bipolar disorder.

Authors:  Koen P Grootens; Anna Meijer; Erwin G Hartong; Bennard Doornbos; P Roberto Bakker; Asmar Al Hadithy; Kirsten N Hoogerheide; Frans Overmeire; Radboud M Marijnissen; Henricus G Ruhe
Journal:  Eur J Clin Pharmacol       Date:  2018-08-07       Impact factor: 2.953

3.  Factors associated with non-persistence to oral and inhaled antiviral therapies for seasonal influenza: a secondary analysis of a double-blind, multicentre, randomised clinical trial.

Authors:  Remi Flicoteaux; Camelia Protopopescu; Annick Tibi; Thierry Blanchon; Sylvie Van Der Werf; Xavier Duval; Anne Mosnier; Cécile Charlois-Ou; Bruno Lina; Catherine Leport; Sylvie Chevret
Journal:  BMJ Open       Date:  2017-07-10       Impact factor: 2.692

4.  Cognitive remediation for bipolar patients with objective cognitive impairment: a naturalistic study.

Authors:  J Veeh; J Kopf; S Kittel-Schneider; J Deckert; A Reif
Journal:  Int J Bipolar Disord       Date:  2017-04-13

5.  Bipolar disorder, comorbid anxiety disorders, gynecomastia and dental pain: case analysis with literature review.

Authors:  Kenneth R Kaufman; Ronke Babalola; Miriam Campeas; Melissa Coluccio
Journal:  BJPsych Open       Date:  2018-04-26

6.  Patient preferences for important attributes of bipolar depression treatments: a discrete choice experiment.

Authors:  Daisy Ng-Mak; Jiat-Ling Poon; Laurie Roberts; Leah Kleinman; Dennis A Revicki; Krithika Rajagopalan
Journal:  Patient Prefer Adherence       Date:  2017-12-28       Impact factor: 2.711

Review 7.  Real-World Patterns of Utilization and Costs Associated with Second-Generation Oral Antipsychotic Medication for the Treatment of Bipolar Disorder: A Literature Review.

Authors:  Michael J Doane; Kristine Ogden; Leona Bessonova; Amy K O'Sullivan; Mauricio Tohen
Journal:  Neuropsychiatr Dis Treat       Date:  2021-02-16       Impact factor: 2.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.